Life Technologies | LIFE - Current Assets



Life Technologies reported $87.49M in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Ardelyx USD 351.57M 4.88M Jun/2025
Biogen USD 7.97B 341.7M Jun/2025
Bristol-Myers Squibb USD 33.22B 2.44B Jun/2025
Cipla INR 232.89B 23.43B Mar/2025
Clal Biotechnology ILS 14.69M 1.95M Dec/2023
Compugen USD 97.64M 8.36M Jun/2025
CSL USD 11.31B 540M Dec/2024
Galapagos EUR 3.26B 217.04M Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
Grifols EUR 5.73B 404.28M Dec/2024
Life Technologies USD 87.49M 5.54M Jun/2025
Novartis USD 25.94B 831M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
United Therapeutics USD 3.83B 112.9M Jun/2025